- Remission induction therapy with TAD for acute myeloid leukemia
-
Sohn CH
- KMID: 2252482
- Korean J Hematol.
- 1991 Oct;26(2):323-330.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Diabetic Ketoacidosis Associated with Acute Lymphocytic Leukemia during Remission Induction Chemotherapy
-
Jin OG, Jeong LH, Jeong KH, Sil LI
- KMID: 1683656
- J Korean Pediatr Soc.
- 1990 Nov;33(11):1598-1603.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of peripheral blood cell counts during remission induction and maintenance therapy on the prognosis and therapy of childhood acute lymphoblastic leukemia
-
Kim JH, Ko DH, Moon DK, Kook H, Hwang TJ
- KMID: 1688310
- Korean J Hematol.
- 1993 May;28(1):81-88.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Sweet Syndrome Developed in a Patient of Acute Promyelocytic Leukemia During Remission Induction Therapy with All-trans Retinoic Acid
-
Lee SK, Kim KW, Park SY
- KMID: 2305240
- Korean J Hematol.
- 1998 Aug;33(2):295-299.
All-trans retinoic acid (RA) is recognized to be a drug of choice in remission induction of acute promyelocytic leukemia (APL), with some side effects including retinoic acid syndrome. But Sweet... -
- CITED
-
- Close
- SHARE
-
- Close
- The effects of shortened dexamethasone administration on remission rate and potential complications during remission induction treatment for pediatric acute lymphoblastic leukemia
-
Lee JW, Lee KH, Kwon YJ, Lee DH, Chung NG, Jeong DC, Cho B, Kim HK
- KMID: 2279454
- Korean J Pediatr.
- 2007 Dec;50(12):1217-1224.
- doi: 10.3345/kjp.2007.50.12.1217
PURPOSE: Due to its high potency against leukemic blasts, our institution has opted for the use of dexamethasone during acute lymphoblastic leukemia (ALL) remission induction, but in our most recent... -
- CITED
-
- Close
- SHARE
-
- Close
- Potential Benefits of Prednisolone Administration Compared to Dexamethasone During Remission Induction Treatment for Childhood Acute Lymphoblastic Leukemia
-
Kim MS, Kim MH, Lee JW, Jang PS, Chung NG, Cho B, Jeong DC, Kim HK
- KMID: 2168943
- Clin Pediatr Hematol Oncol.
- 2010 Oct;17(2):155-162.
PURPOSE: Due to its high potency against leukemic blasts, our institution previously used dexamethasone during acute lymphoblastic leukemia (ALL) remission induction, but in our most recent treatment protocol, CMCPL-2009, we... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of Acute Myelogenous Leukemia in Children: Remission Induction with Adriamycin and Cytosine Arabinoside, and Postremission Maintenance Chemotherapy with Adriamycin, Cytosine Arabinoside and 6-thioguanine
-
Kim SK, Ahn HS, Hong CY
- KMID: 1682617
- J Korean Pediatr Soc.
- 1988 Jul;31(7):850-862.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Treatment with Intensified Induction Regimen in Adult Acute Lymphocytic Leukemia
-
Seok JH, Lee KH, Hyun MS
- KMID: 2038492
- Korean J Hematol.
- 1997 Nov;32(3):376-387.
BACKGROUND: Adult acute lymphocytic leukemia (ALL) is a hematologic malignant disease characterized by an uncontrolled proliferation of immature lymphocytes and their progenitors. Progress in the treatment of adults with ALL... -
- CITED
-
- Close
- SHARE
-
- Close
- Remission induction using arsenic trioxide in acute promyelocytic leukemia
-
Min CK
- KMID: 2256189
- Korean J Med.
- 2008 Jun;74(6):593-595.
In acute promyelocytic leukemia (APL), all-trans retinoic acid (ATRA) triggers cell differentiation, while arsenic trioxide (ATO) generates partial differentiation and apoptosis. Standard initial treatment for patients with APL consists of... -
- CITED
-
- Close
- SHARE
-
- Close
- A complete remission can be achieved despite persistence of abnormal bone marrow promyelocytes in acute promyelocytic leukemia: experience in 2 patients
-
Kim SW, Lee KH, Lee JS, Suh C, Ahn MJ, Kim SW, Chi HS, Kim SH
- KMID: 2157506
- J Korean Med Sci.
- 1993 Aug;8(4):246-250.
- doi: 10.3346/jkms.1993.8.4.246
Acute promyelocytic leukemia (APL) is a distinct subset of acute myeloid leukemia (AML) and is distinguished from other subsets of AML by its distinctive morphology, specific chromosomal abnormality, associated consumptive... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapeutic Results of Two Regimens for Childhood Acute Myelogenous Leukemia
-
Park HJ, Yoon WS, Kim CJ, Oh HA, Kook H, Hwang TJ
- KMID: 2072477
- Korean J Pediatr Hematol Oncol.
- 1999 Apr;6(1):68-77.
PURPOSE: The purpose of this study was to compare the therapeutic results between the two groups of children with acute myelogenous leukemia (AML) who were treated either by 3-year... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Remission Induction Chemotherapy with AD(Cytosine Arabinoside, Daunorubicin) in Adult Acute Myelogenous Leukemia
-
Kim SM, Lee SY, Kim BD, Lee EJ, Lee KH, Hyun MS
- KMID: 1849139
- Korean J Hematol.
- 1998 Oct;33(3):353-362.
BACKGROUND: The goal of acute myelogenous leukemia(AML) therapy is to obtain the complete remission(CR) and to improve disease-free survival. Advances in chemotherapy and supportive care provided significant improvement in CR... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapeutic Efficacy of Exclusive Enteral Nutrition with Specific Polymeric Diet in Pediatric Crohn's Disease
-
Kang Y, Park S, Kim S, Kim SY, Koh H
- KMID: 2430918
- Pediatr Gastroenterol Hepatol Nutr.
- 2019 Jan;22(1):72-79.
- doi: 10.5223/pghn.2019.22.1.72
PURPOSE: The efficacy of exclusive enteral nutrition (EEN) with a polymeric diet has not been confirmed in Korean pediatric patients with Crohn's disease (CD). This study aimed to compare the... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Adalimumab in Korean Patients with Crohn's Disease
-
Sohn IW, Kim ST, Kim B, Lee HJ, Park SJ, Hong SP, Kim TI, Kim WH, Cheon JH
- KMID: 2363971
- Gut Liver.
- 2016 Mar;10(2):255-261.
- doi: 10.5009/gnl15165
BACKGROUND/AIMS: Adalimumab is effective for both remission induction and the maintenance of Crohn's disease (CD) in Western countries. We evaluated the efficacy of adalim-umab in the conventional step-up treatment approach... -
- CITED
-
- Close
- SHARE
-
- Close
- Improvement of Induction Remission Rate by Modifying the Dose of Idarubicin for Relapsed Childhood Acute Lymphoblastic Leukemia
-
Yoon JH, Park JA, Kim EK, Kang HJ, Shin HY, Ahn HS
- KMID: 1779131
- J Korean Med Sci.
- 2009 Apr;24(2):281-288.
- doi: 10.3346/jkms.2009.24.2.281
Relapse is the major cause of treatment failure in acute lymphoblastic leukemia (ALL), yet there is no established treatment for relapsed ALL. To improve the induction remission rate, we modified... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Outcome and Predictive Factors for Remission and Relapse of Proliferative Lupus Nephritis after Intravenous Cyclophosphamide Pulse Therapy
-
Park MC, Lee SW, Park YB, Choi KH, Lee SK
- KMID: 2334797
- J Korean Rheum Assoc.
- 2004 Jun;11(2):105-115.
OBJECTIVE: This study was designed to investigate the clinical outcomes of proliferative lupus nephritis and to identify the predictive factors of remission and relapse of proliferative lupus nephritis after... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparative Study on the Infection Rates of Protected Environment versus Non-Protected Environment in Acute Myeloid Leukemia during Remission Induction Chemotherapy
-
Sohn SH, Lee HY, Kim DG, Park SW, Kim MJ, Oh MJ, Woo HD, Ryoo HM, Bae SH, Lee KH, Kim MK, Hyun MS
- KMID: 1462688
- Yeungnam Univ J Med.
- 2010 Dec;27(2):113-121.
- doi: 10.12701/yujm.2010.27.2.113
BACKGROUND AND PURPOSE: Patients with acute leukemia experience prolonged periods of neutropenia due to their disease or its treatment. For this reason, they often develop serious infectious complications. Although antibiotic... -
- CITED
-
- Close
- SHARE
-
- Close
- Remission Induction by Arsenic Trioxide in Patient with Relapsed Acute Promyelocytic Leukemia after Allogeneic Bone Marrow Transplantation
-
Song HJ, Lee NS, Kim SE, Kim CK, Lee GT, Park SG, Won JH, Baick SH, Hong DS, Park HS
- KMID: 1641959
- Korean J Hematol.
- 2002 Aug;37(3):218-222.
All-trans retinoic acid (ATRA) therapy induces complete remission in acute promyelocytic leukemia (APL) via differentiation of the APL cells. Recent clinical trials in China and United states showed that arsenic... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of Autoimmune Pancreatitis
-
Han J
- KMID: 2448606
- Korean J Pancreas Biliary Tract.
- 2017 Jul;22(3):123-126.
- doi: 10.15279/kpba.2017.22.3.123
Autoimmune pancreatitis is a rare type of chronic pancreatitis. Unlike chronic pancreatitis caused by other causes, autoimmune pancreatitis is characterized by a dramatic response to corticosteroid and immunomodulator therapy. Two... -
- CITED
-
- Close
- SHARE
-
- Close
- The Efficacy and Safety of DA-3030 (Recombinant Human Granulocyte Colony-Stimulating Factor) in Neutropenia after the Remission Induction Chemotherapy in Patients with Acute Myelogenous Leukemia
-
Min YJ, Suh CW, Park KU, Yoon SS, Park CH, Lee HG
- KMID: 1807223
- Cancer Res Treat.
- 2003 Feb;35(1):66-68.
PURPOSE: This study was conducted to determine the efficacy and safety of DA-3030 (a recombinant methionyl human granulocyte colony-stimulating factor, rhG-CSF), after remission induction chemotherapy, in patients with acute myelogenous... -
- CITED
-
- Close
- SHARE
-
- Close
